Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
3 Feb 2025, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
ETHAMBUTOL 800 MG TAB
ISONLAZID 300MG TAB
FLUNARIZINE 5 MG TAB
INJ LIGNOCAINE 2 PERS WITHOUT ADRENALINE VIAL OF 30 ML
FLUCONAZOLE 50 MG CAP OR TAB
LEVOFLOX 500 MG TAB
7367627
GEM/2025/B/5811913
Two Packet Bid
ETHAMBUTOL 800 MG TAB
28 days
JALANDHAR CITY
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹31
80%
Exempted
3 Feb 2025
12 Jan 2025
3 Feb 2025
ECHS CFA RE 114 MED
ETHAMBUTOL 800 MG TAB
ISONLAZID 300MG TAB
FLUNARIZINE 5 MG TAB
INJ LIGNOCAINE 2 PERS WITHOUT ADRENALINE VIAL OF 30 ML
FLUCONAZOLE 50 MG CAP OR TAB
LEVOFLOX 500 MG TAB
ETHAMBUTOL 800 MG TAB
ISONLAZID 300MG TAB
FLUNARIZINE 5 MG TAB
INJ LIGNOCAINE 2% WITHOUT ADRENALINE VIAL OF 30 ML
FLUCONAZOLE 50 MG CAP OR TAB
LEVOFLOX 500 MG TAB Bid Number ( ) : GEM/2025/B/5811913 Dated : 12-01-2025 Bid Document 1/10
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7367627.pdf
GEM_BID
ATC_8fcc9a9f-d9c1-4c1f-9bd41736663877745_USINGH1972.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
echs_re_114_2025-01-12-12-01-23_a9d7e67e18d0bd699b7384221c0a4a7c.pdf
BOQ
boq_item_sample_file_2025-01-12-12-01-23_4ccca74d0be27dd50a064d2c627749ae.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .